ATE469229T1 - Herstellung von sekretierten polypeptiden - Google Patents

Herstellung von sekretierten polypeptiden

Info

Publication number
ATE469229T1
ATE469229T1 AT00941529T AT00941529T ATE469229T1 AT E469229 T1 ATE469229 T1 AT E469229T1 AT 00941529 T AT00941529 T AT 00941529T AT 00941529 T AT00941529 T AT 00941529T AT E469229 T1 ATE469229 T1 AT E469229T1
Authority
AT
Austria
Prior art keywords
production
secreted polypeptides
secretion
polypeptides
interrupting
Prior art date
Application number
AT00941529T
Other languages
English (en)
Inventor
Maria Diaz-Torres
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int filed Critical Genencor Int
Application granted granted Critical
Publication of ATE469229T1 publication Critical patent/ATE469229T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00941529T 2000-06-14 2000-06-14 Herstellung von sekretierten polypeptiden ATE469229T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/016764 WO2001096577A1 (en) 2000-06-14 2000-06-14 Production of secreted polypeptides

Publications (1)

Publication Number Publication Date
ATE469229T1 true ATE469229T1 (de) 2010-06-15

Family

ID=21741502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00941529T ATE469229T1 (de) 2000-06-14 2000-06-14 Herstellung von sekretierten polypeptiden

Country Status (7)

Country Link
EP (1) EP1290194B1 (de)
JP (1) JP4824257B2 (de)
AT (1) ATE469229T1 (de)
AU (1) AU2000256229A1 (de)
DE (1) DE60044468D1 (de)
DK (1) DK1290194T3 (de)
WO (1) WO2001096577A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1495128B1 (de) 2002-03-29 2014-05-07 Genencor International, Inc. Verstärkte proteinexpression in bacillus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0966521A1 (de) * 1996-09-13 1999-12-29 Novo Nordisk Biotech, Inc. Zellen mit dna-insertionsmutationenwelche veränderte mengen eines polypeptids produzieren
GB9724627D0 (en) * 1997-11-20 1998-01-21 Genencor Int Bv Gram positive microorganism formate pathway
GB9828711D0 (en) * 1998-12-24 1999-02-17 Genencor Int Production of proteins in gram-positive microorganisms

Also Published As

Publication number Publication date
EP1290194B1 (de) 2010-05-26
DE60044468D1 (de) 2010-07-08
JP4824257B2 (ja) 2011-11-30
JP2004503244A (ja) 2004-02-05
EP1290194A1 (de) 2003-03-12
WO2001096577A8 (en) 2002-05-30
WO2001096577A1 (en) 2001-12-20
AU2000256229A1 (en) 2001-12-24
DK1290194T3 (da) 2010-09-20

Similar Documents

Publication Publication Date Title
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
DE60032367D1 (de) Aktivierbare rekombinante neurotoxine
TR199501669A1 (tr) Peptid ve proteinlerin aerosol formülasyonlari.
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
DE60144145D1 (de) Subtilisin-variante
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
KR950700990A (ko) 신규의 분비단백질 에프-스폰딘의 클로닝, 발현 및 용도
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
WO2004007695A3 (en) Lactobacilli expressing biologically active polypeptides and uses thereof
HRP20050024A2 (en) Pegylated t20 polypeptide
ATE363531T1 (de) Claudin polypeptide
ID15848A (id) Produksi dan sekresi protein-protein yang berasal dari bakteri dalam jamur berfilamen
NO20031860L (no) Kahalalid F
DE59711957D1 (de) Rekombinante blutgerinnungsproteasen
ATE438658T1 (de) Neue polypeptide aus bienengift und dessen gebrauchsverfahren
AU2001275267A1 (en) Leader peptides for enhancing secretion of recombinant protein from a host cell
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DE60014856D1 (de) Zusammensetzungen zur modulierung der schleimsekretion
ATE291080T1 (de) Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
ATE469229T1 (de) Herstellung von sekretierten polypeptiden
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
FR2692907B1 (fr) Levures kluyveromyces modifiees, preparation et utilisation.
DE69938130D1 (de) Neue peptide
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties